Used as a chiral building block in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs) where stereochemistry plays a critical role in biological activity. Its trifluoromethyl group enhances metabolic stability and lipophilicity, making it valuable in optimizing drug candidates for improved bioavailability and binding affinity. Commonly employed in the synthesis of central nervous system (CNS) agents and protease inhibitors. Also utilized in agrochemicals for creating bioactive molecules with enhanced environmental stability.